Delivery Order SPE2DB22D3004-SPE2DB23FQU30
Award Date 7/24/23
Potential Completion Date 7/25/23
Potential Value $67
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $903.60 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 150 mg/ml medroxyprogesterone. The contract has a period of performance from September 1, 2023 through September 5, 2023, with all work to be conducted by the prime contractor at its facility in Conshohocken, Pennsylvania. No additional details were provided regarding the original solicitation or whether this delivery order is associated with any broader IDIQ...
- The Defense Logistics Agency awarded a $423,840 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the provision of 150 mg/ml medroxyprogesterone. The single day contract has a period of performance from June 21, 2023 through June 22, 2023 and will be performed in Conshohocken, Pennsylvania. Amerisourcebergen will supply the pharmaceutical product to the DLA, the Department of Defense's combat logistics support agency, in support of its mission to provide medical...
- The Defense Logistics Agency awarded a $12,600 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 150 mg/ml medroxyprogesterone. As the prime contractor, Amerisourcebergen will supply the pharmaceutical product to the DLA under a one-day contract spanning August 24-25, 2023. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, will perform the order from its facility in Conshohocken, Pennsylvania. No subcontractors or set aside designations were identified....
- The Defense Logistics Agency awarded a $731.60 delivery order contract to Amerisourcebergen Drug Corporation for the provision of 150 mg/ml medroxyprogesterone. The firm fixed price contract has a period of performance from July 11, 2023 through July 12, 2023 and will be performed in Conshohocken, Pennsylvania. No additional details were provided regarding the original solicitation or whether this delivery order was issued against an existing indefinite-delivery/indefinite-quantity contract...
- The Defense Logistics Agency awarded a $365.80 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the provision of 150 mg/ml medroxyprogesterone. The single award delivery order was issued against an indefinite-delivery/indefinite-quantity contract vehicle and calls for the contractor to deliver the pharmaceutical item to a location in Conshohocken, Pennsylvania between August 11-14, 2023. No subcontractors or set aside designations were identified. The Defense Logistics...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,643 to Amerisourcebergen Drug Corporation for the provision of 150 mg/ml medroxyprogesterone. The single award was issued under an unspecified governmentwide acquisition contract vehicle and will be performed by Amerisourcebergen at its facility in Conshohocken, Pennsylvania over a period of one day, from July 18, 2023 through July 19, 2023. No subcontractors or set aside designations were...
- The Defense Logistics Agency awarded a $102,600 delivery order to Amerisourcebergen Drug Corporation for 150 mg/mL medroxyprogesterone. The prime contractor, a subsidiary of Amerisourcebergen Corporation, will provide the pharmaceutical product from its Conshohocken, Pennsylvania facility. The firm fixed price, single day order was issued under an existing DLA contract vehicle on July 11, 2023 for delivery the following day. No subcontractors or set aside designations were identified. The...
- The Defense Logistics Agency awarded a $409,500 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the provision of 150 mg/ml medroxyprogesterone. The single award delivery order was issued against an indefinite-delivery/indefinite-quantity contract vehicle and calls for the contractor to deliver the pharmaceutical item to a location in Conshohocken, Pennsylvania between July 14-17, 2023. No subcontractors or set aside designations were identified. The Defense Logistics...
- The Defense Logistics Agency awarded a $189,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the provision of 150 mg/ml medroxyprogesterone. The single day contract has a period of performance from August 3rd to August 4th, 2023, with pricing that will remain fixed over the term of the contract. Amerisourcebergen will fulfill the order from its facility located in Conshohocken, Pennsylvania. No subcontractors or set aside designations were identified. The Defense...
- The Defense Logistics Agency awarded a $2,749.79 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the provision of 150 mg/ml medroxyprogesterone. As the prime contractor, Amerisourcebergen will deliver the specified pharmaceutical to the agency from its facility in Conshohocken, Pennsylvania. Performance is required between August 31, 2023 and September 1, 2023 to support the Defense Logistics Agency's medical supply chain needs. No subcontractors or set aside...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB23FQU30Delivery Order
The Defense Logistics Agency awarded a $67,260 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the provision of 150 mg/ml medroxyprogesterone. The single day contract has a period of performance from July 24, 2023 through July 25, 2023 and will be performed in Conshohocken, Pennsylvania. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order for the generic hormone drug is consistent with DLA's role in supporting essential healthcare needs for military members. No set aside designation or subcontractors were identified.
Generated 12/18/23, 8:27 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $67 | 7/24/23 |